These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 9033469)

  • 21. Kaposi sarcoma-associated herpesvirus/human herpesvirus type 8 and Epstein-Barr virus in immunosuppressed renal transplant recipients.
    Demirağ A; Hizel N; Karakayali H; Moray G; Akkoç H; Bilgin N; Haberal M
    Transplant Proc; 1998 Nov; 30(7):3166-7. PubMed ID: 9838400
    [No Abstract]   [Full Text] [Related]  

  • 22. Kaposi sarcoma in a paediatric renal transplant recipient.
    Ozen S; Saatci U; Karaduman A; Buyukpamukcu M; Gokoz A; Besbas N; Bakkaloglu A
    Nephrol Dial Transplant; 1996 Jun; 11(6):1162-3. PubMed ID: 8671991
    [No Abstract]   [Full Text] [Related]  

  • 23. Results of clinical renal transplantation in 15 dogs using triple drug immunosuppressive therapy.
    Gregory CR; Kyles AE; Bernsteen L; Mehl M
    Vet Surg; 2006 Feb; 35(2):105-12. PubMed ID: 16472290
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dislipidemia at different immunosuppressive protocols.
    Zezina L; Rosental R
    Transplant Proc; 1994 Dec; 26(6):3223. PubMed ID: 7998123
    [No Abstract]   [Full Text] [Related]  

  • 25. Demodex folliculorum in renal transplant patients.
    Aydingöz IE; Mansur T; Dervent B
    Dermatology; 1997; 195(3):232-4. PubMed ID: 9407168
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Kaposi's sarcoma associated with immunosuppression for bullous pemphigoid.
    Halpern SM; Parslew R; Cerio R; Kirby JT; Sharpe GR
    Br J Dermatol; 1997 Jul; 137(1):140-3. PubMed ID: 9274643
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Neoplastic skin lesions in Iranian renal transplant recipients: the role of immunosuppressive therapy.
    Zamanian A; Farshchian M
    J Drugs Dermatol; 2007 Jul; 6(7):703-6. PubMed ID: 17763593
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immunosuppressive treatment after solid organ transplantation and risk of post-transplant cutaneous squamous cell carcinoma.
    Ingvar A; Smedby KE; Lindelöf B; Fernberg P; Bellocco R; Tufveson G; Höglund P; Adami J
    Nephrol Dial Transplant; 2010 Aug; 25(8):2764-71. PubMed ID: 19729465
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Skin cancer in liver transplant recipients.
    Otley CC; Pittelkow MR
    Liver Transpl; 2000 May; 6(3):253-62. PubMed ID: 10827224
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Skin cancers in kidney transplant recipients].
    Bieryło A; Brzósko S; Laudańska E; Naumnik B
    Wiad Lek; 2017; 70(1):68-73. PubMed ID: 28343197
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Skin cancer following kidney transplantation: a single-center experience.
    Karczewski M; Stronka M; Karczewski J; Wiktorowicz K
    Transplant Proc; 2011 Dec; 43(10):3760-1. PubMed ID: 22172842
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Lymphoproliferative syndromes after cardiac transplantation and treatment with cyclosporine. Report of 4 cases].
    Guerci AP; Burtin P; Mattei S; Lederlin P
    Ann Med Interne (Paris); 1992; 143(3):155-9. PubMed ID: 1524349
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The risk of skin cancer in renal transplant recipients in Queensland, Australia. A follow-up study.
    Bouwes Bavinck JN; Hardie DR; Green A; Cutmore S; MacNaught A; O'Sullivan B; Siskind V; Van Der Woude FJ; Hardie IR
    Transplantation; 1996 Mar; 61(5):715-21. PubMed ID: 8607173
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Epidemiological profile of nonmelanoma skin cancer in renal transplant recipients: experience of a referral center.
    Ferreira FR; Ogawa MM; Nascimento LF; Tomimori J
    An Bras Dermatol; 2014; 89(5):745-50. PubMed ID: 25184913
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Patients with solid organ transplantation and skin cancer: determination of risk factors with emphasis in photoexposure and immunosuppressive regimen. Experience in a third level hospital].
    Rodríguez-Acosta ED; Calva-Mercado JJ; Alberú-Gómez J; Vilatoba-Chapa M; Domínguez-Cherit J
    Gac Med Mex; 2015; 151(1):20-6. PubMed ID: 25739480
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Malignant tumours following immunosuppression in renal transplantation.
    Birkeland SA; Kemp E
    Proc Eur Dial Transplant Assoc; 1973; 10(0):429-33. PubMed ID: 4370181
    [No Abstract]   [Full Text] [Related]  

  • 37. Effect of long-term immunosuppression in kidney-graft recipients on cancer incidence: randomised comparison of two cyclosporin regimens.
    Dantal J; Hourmant M; Cantarovich D; Giral M; Blancho G; Dreno B; Soulillou JP
    Lancet; 1998 Feb; 351(9103):623-8. PubMed ID: 9500317
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Update on the pathogenesis of post-transplant skin cancer in renal transplant recipients.
    Ho WL; Murphy GM
    Br J Dermatol; 2008 Feb; 158(2):217-24. PubMed ID: 18070205
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The problems associated with conversion from azathioprine and prednisolone to cyclosporine.
    Chapman JR; Taylor HM; Thompson JF; Wood RF; Morris PJ
    Uremia Invest; 1985-1986; 9(1):19-25. PubMed ID: 3915162
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Verrucous carcinoma in a reanl transplant patient after long-term immunosuppression.
    Turner JE; Hodge SJ; Callen JP
    Arch Dermatol; 1980 Sep; 116(9):1074-6. PubMed ID: 6998379
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.